LRRK2 and Parkinson disease: This global decrease in protein synthesis has recently been shown to be mediated by LRRK2 [30], as treatment of idiopathic PD and LRRK2 (G2019S) PD fibroblasts with LRRK2 inhibitors rescued the defect.